Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Inhibitors targeting the general RNA polymerase II (RNAPII) transcription machinery are candidate therapeutics in cancer and other complex diseases. Here, we review the molecular targets and mechanisms of action of these compounds, framing them within the steps of RNAPII transcription. We discuss the effects of transcription inhibitors in vitro and in cellular models (with an emphasis on cancer), as well as their efficacy in preclinical and clinical studies. We also discuss the rationale for inhibiting broadly acting transcriptional regulators or RNAPII itself in complex diseases.


Ryan D Martin, Terence E Hébert, Jason C Tanny. Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery. International journal of molecular sciences. 2020 May 09;21(9)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32397434

View Full Text